Comparison of Biological Properties and Clinical Application of Mesenchymal Stem Cells from the Mesoderm and Ectoderm

Wang, Zhenning; Huang, Meng; Zhang, Yu; Jiang, Xiaoxia; Xu, Lulu

doi:https://doi.org/10.1155/2023/4547875

Stem Cells International

On this page

Abstract Introduction Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Review Article | Open Access

Volume 2023 | Article ID 4547875 | https://doi.org/10.1155/2023/4547875

Comparison of Biological Properties and Clinical Application of Mesenchymal Stem Cells from the Mesoderm and Ectoderm

Zhenning Wang,^1,2Meng Huang,^1,2Yu Zhang,^1,2Xiaoxia Jiang ,³and Lulu Xu²

Academic Editor: Stefan Arnhold

Received10 May 2022

Revised04 May 2023

Accepted23 May 2023

Published10 Jun 2023

Abstract

Since the discovery of mesenchymal stem cells (MSCs) in the 1970s, they have been widely used in the treatment of a variety of diseases because of their wide sources, strong differentiation potential, rapid expansion in vitro, low immunogenicity, and so on. At present, most of the related research is on mesoderm-derived MSCs (M-MSCs) such as bone marrow MSCs and adipose-derived MSCs. As a type of MSC, ectoderm-derived MSCs (E-MSCs) have a stronger potential for self-renewal, multidirectional differentiation, and immunomodulation and have more advantages than M-MSCs in some specific conditions. This paper analyzes the relevant research development of E-MSCs compared with that of M-MSCs; summarizes the extraction, discrimination and culture, biological characteristics, and clinical application of E-MSCs; and discusses the application prospects of E-MSCs. This summary provides a theoretical basis for the better application of MSCs from both ectoderm and mesoderm in the future.

1. Introduction

As an important member of the stem cell family, mesenchymal stem cells (MSCs) are widely distributed and easy to extract and culture and have self-replication ability and strong differentiation potential. MSCs also have the ability to migrate to damaged tissues and regulate the immune response according to the microenvironment, which is why they are being increasingly applied in tissue engineering and clinical research.

MSCs are derived from the mesoderm and ectoderm in early development. Leucht et al. [1] proposed that damaged tissue from different germ layers will recruit MSCs from the corresponding germ layers for repair. Moreover, the proliferation and differentiation abilities of MSCs from different tissues are also different [2]. This paper comprehensively compares the biological characteristics and clinical application of mesenchymal stem cells from the mesoderm and ectoderm, as well as the possible development direction in the future.

2. Basic Introduction

2.1. Mesoderm-Derived MSCs (M-MSCs)

A rich source of M-MSCs is an important basis for their extensive research and application. Bone marrow is an important source of MSCs. In addition to bone marrow, M-MSCs also exist in various tissues and organs. In 2000, human umbilical cord blood stem cells were first reported [3]. Subsequently, in 2001, adipose tissue and synovium were also proven to be rich sources of M-MSCs [4, 5]. The extraction method of M-MSCs, in short, includes separating various tissues, digesting the tissues to obtain cells, culturing the cells for 3 to 5 days, discarding nonadherent cells, and continuously culturing adherent cells to the desired passage [6].

2.2. Ectoderm-Derived MSCs (E-MSCs)

E-MSCs are mainly divided into three types: osteogenic (T.Q. [7]), odontogenic, and olfactory mucosal. Odontogenic stem cells include dental pulp stem cells (DPSCs), dental follicle stem cells (DFSCs), apical dental papilla stem cells (SCAPs), deciduous dental pulp stem cells (SHEDs), and periodontal ligament stem cells (PDLSCs). Sources and markers of odontogenic stem cells are listed in Figure 1. DPSCs were first isolated from adult dental pulp in 2001 [8]. DFSCs were isolated and identified from the dental sac of human third molars by Morsczeck et al. [9] in 2005. Sonoyama et al. [10] first found and identified SCAPs from the apical papilla of extracted third molars in 2006. SCAPs come from developing tissues. Therefore, SCAPs may have better regeneration potential than other mature tissues. Miura et al. (S. Shi) first discovered SHEDs in 2003. SHEDs can differentiate into a variety of cell types, including nerve cells, adipocytes, and odontoblasts. In addition, after injection into the dentate gyrus of the mouse hippocampus, SHEDs can differentiate into neural tissue and express neuronal and glial markers, indicating that SHEDs can be used for dental pulp and nerve regeneration. PDLSCs were isolated and identified from the surface of tooth roots by Seo et al. [11] in 2004. In 2009, Zhang et al. [12] first reported the isolation, characterization, and immunomodulatory properties of gingival mesenchymal stem cells (GMSCs) and found that GMSCs can inhibit the proliferation of peripheral blood monocytes induced by phytohemagglutinin. Olfactory mucosal stem cells (OMSCs) are MSCs isolated from the olfactory mucosal epithelium. Studies have shown that MSCs may play a better role in promoting the formation of the myelin sheath in the central nervous system and in repairing nerve injury than MSCs from other tissues [13].

3. Extraction, Discrimination, and Culture

Theoretically, MSCs can be isolated from all tissues. For example, M-MSCs mainly come from the bone marrow, adipose tissue, placenta and human umbilical cord blood, while E-MSCs mainly come from the dental pulp, the jaw, the frontal bone, the periodontal ligament, the gingiva, and the dental papilla. Han et al. [6] summarized the extraction, identification, and culture methods of several common M-MSCs. For comparison, in Table 1, the authors summarized the extraction, identification, and culture of several common E-MSCs. In Figure 2, the extraction process of DPSCs is described in the form of a schematic.

4. Biological Properties

Regardless of the source of MSCs, they all show some common characteristics, such as fibroblast-like morphology, cell surface markers, cell proliferation ability, and multidirectional differentiation potential. However, the biological properties of MSCs from different tissues or the same kind of MSCs under different conditions are slightly different.

4.1. Cell Proliferation Ability

According to Miura et al. (S. Shi), SHEDs have a higher proliferation rate and population doubling efficiency than DPSCs and bone marrow mesenchymal stem cells (BMMSCs). In addition, SHEDs are separated from deciduous teeth, so they can be easily obtained without ethical considerations. The transition from deciduous teeth to permanent teeth is a unique dynamic process. The dental pulp of deciduous teeth already exists before birth, indicating that these stem cells are not affected or are less affected by environmental factors than other stem cells [14]. Akintoye et al. [35] compared MSCs from maxillofacial and lower limb bone marrow, and the results showed that the proliferation rate of jaw bone marrow MSCs from maxillofacial-bone marrow was faster than that of iliac bone marrow MSCs from lower limb bone marrow. Moreover, compared with long bone marrow MSCs, jaw bone marrow MSCs showed stronger proliferation and antiapoptotic potential [7, 20]. In embryology, the iliac bone and long bone are derived from the mesoderm, while the jaw is derived from the ectodermal neural crest. Interestingly, studies have shown that cells expressing neural crest markers have stronger stem cell properties and stronger proliferation potential than M-MSCs [2]; thus, they contribute to the survival of MSCs under hypoxia after transplantation [21, 36].

4.2. Multidirectional Differentiation

Regardless of the kind of tissue source, MSCs have multidirectional differentiation potential. Multidirectional differentiation potential is one of the important characteristics of MSCs. The differentiation trend of different tissue sources is also different. The jaw develops from the neural crest cells of ectoderm [37], while the mesenchymal cells of mesoderm develop into the long bones of the limbs [38], and the osteogenic processes experienced by the two bone tissues are also different in the development process [37]. In some diseases, such as osteoporosis and hyperthyroidism, the involvement of the long bone is significantly higher than that of the jaw [39]. Some studies have shown that compared with bone marrow MSCs of long bones of limbs, jawbone marrow MSCs have stronger osteogenic activity. This may be due to the high expression of BMP-4, nestin, and other neural crest-related genes in jawbone marrow MSCs at the transcriptional level [2], which is consistent with the research results of Aghaloo et al. [40].

Central and peripheral nerve injuries are difficult to treat, because the ability of the nervous system to repair damaged cells and tissues is limited. In this regard, E-MSCs have obvious advantages because they can differentiate into neuron-like cells and express neuronal markers, such as STRO-1, nestin, c-FOS, GFAP, and β III-tubulin [41–45]. Although these cells can differentiate into neuron-like cells, they do not further differentiate into functional neurons [41]. On this basis, Kiraly et al. found that simultaneous activation of PKC and cAMP can induce hDPSCs to differentiate into functional neurons [43].

At present, research in the field of nerve regeneration mainly focuses on DPSCs and SHEDs [19, 46, 47]. This may be due to the relationship between their tissue origins. In the process of tooth development, the tooth germ is composed of an enamel organ, dental papilla, and dental sac. DPSCs, SHEDs, and SCAPs are derived from dental papilla; DFSCs and PDLSCs are derived from dental sac; and dental pulp is derived from dental papilla. This shows that DPSCs, SHEDs, and SCAPs are highly homologous with dental pulp at the histological level. At the same time, the extraction difficulty and conditions of SCAPs are more stringent than those of DPSCs and SHEDs. Therefore, DPSCs and SHEDs may be a possible direction for pulp regeneration and even central nerve repair in the future.

Compared with bone marrow MSCs, odontogenic MSCs are more convenient to obtain and easy to expand and preserve, have high activity, and have low immunogenicity and tumorigenicity, and these characteristics make them more conducive to clinical application [7, 48]. The multiple differentiation potential and the derivation of MSCs derived from ectodermal cells are summarized in Table 2. The difference in germ layer origin makes the phenotype of odontogenic MSCs different from that of MSCs, such as BMMSCs.

4.3. Age-Related Changes

As the application potential of E-MSCs has been gradually explored, the preparation of sufficient E-MSCs has become a research hotspot, but it is also one of the obstacles that hinders the clinical application of E-MSCs. The age of the MSC donor has a great impact on cell proliferation activity, differentiation potential, and paracrine effect, but the specific effect is still not clear; particularly, whether elderly patients can undergo autologous stem cell therapy is currently controversial [79].

At present, research on the age-related changes in E-MSCs mainly focuses on DPSCs, and there are relatively few studies on other stem cells. In the dental pulp of aged individuals, the proportion of cells decreases, and the proportion of fiber and collagen components gradually increases with age [80]. Mitsiadis et al. [81] showed that pulp volume gradually decreases with age due to continuous production of dentin matrix by odontoblasts, which may explain, at least in part, why DPSC extraction from permanent teeth from old donors is less efficient.

Current studies on age-related changes in the biological activity of DPSCs have shown conflicting results, with some studies showing that the proliferation and differentiation potential of MSCs are independent of age [82]. However, other studies have shown that the proliferation ability, differentiation potential, and cell surface marker expression of DPSCs are affected by age [83, 84]. Therefore, young DPSCs should be collected and preserved as soon as possible, as this may be a potential treatment for elderly patients with dental diseases in the future.

4.4. Immunomodulation

4.4.1. Immune Regulation Mechanism of MSCs

MSCs can interact with a variety of immune cells, including T cells, dendritic cells (DCs), B cells, macrophages, neutrophils, and natural killer (NK) cells [85]. Studies have shown that the immunosuppressive effect of MSCs is mainly the result of the joint action of intercellular contact and soluble immune factors [86, 87]. Soluble immune factors, including a variety of immune regulatory factors, cytokines, and growth factors, such as prostaglandin E2 (PGE-2), indoleamine 2,3-dioxygenase (IDO), and nitric oxide (NO), can respond to immune cells and activate the immune regulation of MSCs [88, 89]. In addition, indirect or direct cell contact can also cause the immunosuppressive effects of MSCs, which are mainly mediated by programmed cell death ligand 1, programmed cell death ligand 2, and membrane-bound human leukocyte antigen [90].

MSCs can also induce chemotaxis to inflammatory sites to exert immune regulation and repair damaged cells and tissues [91, 92]. Interestingly, the immunomodulatory effect of MSCs can not only inhibit the immune response but also enhance it, and which effect they have mainly depends on the function of immunosuppressants, the types of inflammatory factors, and the state of the immune system [93]. MSCs not only respond to inflammatory cytokines but also secrete immunoregulatory molecules and participate in the regulation of the inflammatory process. For example, IDO, NO, and chemokines secreted by MSCs play key roles in MSC-mediated immune regulation [94].

4.4.2. Immunomodulatory Effect of E-MSCs

E-MSCs are similar to MSCs from other tissues and can regulate the activities of different immune cells [26, 95]. The immunomodulatory activity of E-MSCs is usually activated by inflammatory cytokines produced by immune cells, which indicates that there is an interaction between E-MSCs and activated immune cells. The interactions between E-MSCs and immune cells are listed in Table 3. MSCs can have a significant impact on immune cells.

(1) Peripheral Blood Mononuclear Cells (PBMCs). Peripheral blood mononuclear cells (PBMCs) are mononuclear cells in peripheral blood, including lymphocytes and monocytes. E-MSCs can inhibit the proliferation of peripheral blood monocytes through paracrine signaling [12, 17, 28, 95–97], and γ-interferon treatment can enhance this ability [95].

(2) Myeloid Dendritic Cells (DCs). Myeloid dendritic cells (DCs) maintain and regulate the immune response by accelerating the process of antigen-specific T cells and the activation of cells in the innate immune response after DC maturation [98, 99]. Studies have shown that E-MSCs have an immunosuppressive function on DCs, which can inhibit DC maturation and differentiation through a prostaglandin E2-dependent mechanism [100, 101].

(3) Mast Cells. Mast cells are widely distributed around microvessels under the skin and visceral mucosa and can secrete a variety of cytokines. It has been reported that E-MSCs can inhibit the release of inflammatory cytokines by mast cell 1 (HMC-1) through a prostaglandin E2-dependent mechanism but have no effect on the proliferation of HMC-1 cells [101].

(4) Macrophages. Macrophages are cells with significant plasticity in the immune system [102], and they can polarize into M1 or M2 macrophages [103]. Generally, M1 macrophages have significant antibacterial properties enacted by the release of a variety of chemokines and inflammatory cytokines, while M2 macrophages can reduce inflammation and accelerate tissue repair by secreting IL-10 and nutritional factors [104]. In addition, macrophages can be cocultured with MSCs to induce M2 macrophages [27, 105]. Transplantation of DPSCs into unilateral hind limb skeletal muscle can inhibit the occurrence of sciatic nerve inflammation [106]. In specific cases, for example, lipopolysaccharide-treated PDLSCs can promote the polarization of macrophages to the inflammatory M1 phenotype [107].

(5) T Cells. T cells are widely distributed in animal and human tissues. Once activated, they can differentiate into helper T cell (Th) 1 and the regulatory T cell (Treg) subsets Th2, Th9, and Th17 according to the stimulation intensity and microenvironment [108, 109]. It has been proven that MSCs have a close relationship with T cells [87, 110].

MSCs secrete a large number of immunosuppressive factors, chemokines, and adhesion molecules that can effectively inhibit the proliferation, apoptosis, and differentiation of T cells [92, 111]. It has been reported that E-MSCs can inhibit T cell proliferation [24, 29, 112, 113], induce T cell apoptosis, and stimulate regulatory T cell differentiation [114]. E-MSCs induce the immunomodulatory effect of T cell apoptosis, which has an anti-inflammatory effect in vivo [115]. Interestingly, although there are few relevant studies comparing the immunomodulatory ability of MSCs from different germ layers, there is evidence that human gingival MSCs have a stronger inhibitory effect on the proliferation and Th1/Th2/Th17 differentiation of mouse CD4⁺ T cells than BMSCs [26]. Comparison of the immunomodulatory ability of MSCs from different germ layers may be a future research focus of E-MSCs.

(6) B Cells. B cells mainly resist and hunt down foreign pathogens by producing specific antibodies [116, 117]. At present, there are relatively few studies on the effect of E-MSCs on B cells. Kwack et al. [17] found that DPSCs can inhibit the production of immunoglobulin by B cells. However, it has also been reported that MSCs inhibit the production of antibodies by B cells depending on the intensity of inflammatory stimulation and the ratio of BMSCs to B cells [118, 119].

The immunomodulatory properties of MSCs depend on the surrounding microenvironment. Activation of E-MSCs by inflammatory factors, such as γ-interferon, tumor necrosis factor α, and interleukin-1 β, can significantly enhance their immunomodulatory ability [120]. Activated immune cells can upregulate the expression of MSC-related proteins [121]. Activated immune cells play a key role in inducing the immunomodulatory potential of MSCs, and there is a close relationship between these cells.

5. Clinical Application

Studies have proven that E-MSCs are ideal seed cells for tissue engineering. DPSCs have been used to treat severe limb ischemia, tissue defects, and bone necrosis, to regenerate skin damage caused by burns, and to generate liver, nerve, skeletal muscle, blood vessels, and skin [122, 123] and have been shown to have good application prospects [124]. Odontogenic MSCs from third molars, orthodontic teeth, and deciduous teeth have been applied to dentin, periodontal tissue, dental pulp tissue, jaw defect repair, and other in vivo and in vitro studies and have been shown to have good regeneration ability [125].

Due to the same source of dental pulp tissue, E-MSCs have incomparable advantages in the field of dental pulp regeneration compared with M-MSCs, which is also a research hotspot of clinical application of E-MSCs. The majority of tooth loss is due to dental caries and root fractures. At present, root canal therapy is still the main treatment for pulpitis. However, the risk of root fracture is greatly increased due to the lack of nutrition from the pulp of the tooth after endodontic treatment. Therefore, the regenerative restoration of dental pulp has become the goal of functional tooth restoration. Gronthos et al. [8] first demonstrated the ability of DPSCs to differentiate into odontoblasts in 2000. SHEDs can be injected into the dental pulp cavity using injectable scaffold materials, which can not only maintain the nerve activity of dental pulp but also reconstruct the vascularized dental pulp tissue and have the ability to differentiate into odontoblasts [126].

Pulp regeneration of pulpless teeth has always been a dream of dentists and researchers. However, there are still many problems, including the longtime pulp regeneration and the use of scaffold materials that increase the risk of inflammation and infection. The dental pulp regeneration therapy technology established by scaffold-free 3D DPSC constructs avoids the potential problems caused by scaffold materials in transplanted pulp-like tissues [126]. Histological analysis showed that the transplanted DPSC constructs were differentiated into odontoblast-like cells at the site of contact with dentin and were able to form a vascular pulp-like tissue without the need for scaffolds or growth factors. The establishment and development of this technique suggest that the transplantation of DPSCs holds promise for the regeneration of pulp tissue in pulpless teeth.

Odontogenic MSCs also have a strong immunomodulatory effect. They can induce immune tolerance and reduce tissue damage caused by inflammatory reactions, which is conducive to the recovery and prognosis of damaged tissues. They have been applied to the immunomodulatory treatment of a variety of immune system diseases, such as systemic lupus erythematosus, colitis, and multiple sclerosis. After receiving stem cells or their secretions, symptoms related to these diseases can be alleviated. DPSCs are also expected to be able to treat type 2 diabetes and rheumatoid arthritis [127].

By May 2023, more than 12,000 clinical trials of MSCs had been retrieved from the ClinicalTrials.gov website. Internationally, approved MSC drugs have been listed in the United States, South Korea, Japan, and the European Union, and stem cell therapy has become a reality. Although E-MSCs have good biological properties and immunomodulatory ability, it is worth considering that their clinical application is far from that of M-MSCs. According to incomplete statistics, there are 11 MSC drugs approved for marketing worldwide (Table 4), including the United States (1), the European Union (2), Japan (3), South Korea (4), India (1), Australia (1), and Canada (1). From a review of the clinical trials obtained from the ClinicalTrials.gov website, we discovered that all the seed cells of stem cell drugs approved for clinical application are from the mesoderm, and no stem cell drugs from the ectoderm have been listed anywhere in the world.

What is the reason for this? We hypothesized that although the biological properties of E-MSCs are more suitable for tissue engineering, researchers have spent a relatively short amount of time researching them. BMSCs were first discovered 50 years ago, but the earliest E-MSCs were discovered approximately 20 years ago. Compared with MSCs from other sources, such as BMSCs and ADSCs, the foundation of E-MSC research is not strong enough, and relevant supporting research is not sufficient. It will take more time to study the biological properties and immune regulation characteristics of E-MSCs. Second, due to the short research time and imperfect supporting conditions, different researchers have different methods to isolate and culture E-MSCs. Different culture conditions, such as serum, cell inoculation density, and oxygen partial pressure, may affect cell proliferation and differentiation potential [128, 129]. Therefore, it is necessary to formulate an international unified standard process for the isolation, extraction, identification, and culture of E-MSCs. The age of donors also affects the proliferation and differentiation potential of MSCs. Studies have shown that MSCs from young donors show less damage and better proliferation [130].

In the field of tissue engineering, scaffold material is an indispensable factor. It can provide an environment for MSCs to perform their functions and is conducive to the further development of the therapeutic role of MSCs. The scaffold material for E-MSCs can improve the therapeutic effect of stem cells, and there is relatively little research in this field, which may also be one of the factors that hinders the further application of E-MSCs in regenerative medicine.

6. Summary

Both E-MSCs and M-MSCs have good self-renewal and multidirectional differentiation potential; are convenient and safe to extract, expand, and preserve; and have fewer ethical concerns. They are potential seed cells for tissue regeneration, repair, and clinical treatment in the future. However, the clinical application of E-MSCs is still limited. Research on the biological role, mechanism, and regulation after entering the host and differentiation into other tissues is still in the initial stage.

E-MSCs are valuable resources for regenerative medicine. The excellent differentiation potential of E-MSCs provides a new opportunity for the development of different research fields such as metabolic diseases, tumors, and injury repair. DPSC culture technology based on tissue engineering 3D scaffolds has great potential in dental pulp tissue regeneration. It is worth mentioning that the advantages of E-MSCs in neuronal differentiation are helpful for the research of many neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, TBI, and peripheral nerve injury. E-MSC transplantation may become an effective treatment for restoring neurological function.

Further development of materials, science, molecular biology, and tissue engineering technology combined with increased understanding of the biological properties of MSCs from different germ layers will promote the clinical application of E-MSCs. And E-MSCs are expected to become a mature clinical technology and have a bright application prospect in the field of regenerative medicine, creating new alternative treatment options for a variety of diseases.

Data Availability

All the data indicated in this study are available upon request by contacting the corresponding authors.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

This study was supported by grants from the National Natural Science Foundation of China (No. 82170986 to LLX).

References

P. Leucht, J. B. Kim, R. Amasha, A. W. James, S. Girod, and J. A. Helms, “Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration,” Development, vol. 135, no. 17, pp. 2845–2854, 2008.
View at: Publisher Site | Google Scholar
B. Lloyd, B. C. Tee, C. Headley, H. Emam, S. Mallery, and Z. Sun, “Similarities and differences between porcine mandibular and limb bone marrow mesenchymal stem cells,” Archives of Oral Biology, vol. 77, pp. 1–11, 2017.
View at: Publisher Site | Google Scholar
A. Erices, P. Conget, and J. J. Minguell, “Mesenchymal progenitor cells in human umbilical cord blood,” British Journal of Haematology, vol. 109, no. 1, pp. 235–242, 2015.
View at: Publisher Site | Google Scholar
C. D. Bari, F. Dell'Accio, P. Tylzanowski, and F. P. Luyten, “Multipotent mesenchymal stem cells from adult human synovial membrane,” Arthritis & Rheumatology, vol. 44, no. 8, pp. 1928–1942, 2001.
View at: Publisher Site | Google Scholar
P. A. Zuk, M. Zhu, H. Mizuno et al., “Multilineage cells from human adipose tissue: implications for cell-based therapies,” Tissue Engineering Part A, vol. 7, no. 2, pp. 211–228, 2001.
View at: Publisher Site | Google Scholar
Y. Han, X. Li, Y. Zhang, Y. Han, F. Chang, and J. Ding, “Mesenchymal stem cells for regenerative medicine,” Cell, vol. 8, no. 8, 2019.
View at: Publisher Site | Google Scholar
T. Q. Li, X. B. Meng, Q. Shi, and T. Zhang, “Research progress in biological characteristics and influencing factors of jaw bone marrow mesenchymal stem cell,” Zhonghua Kou Qiang Yi Xue Za Zhi, vol. 57, no. 1, pp. 107–112, 2022.
View at: Publisher Site | Google Scholar
S. Gronthos, M. Mankani, J. Brahim, P. G. Robey, and S. Shi, “Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 25, pp. 13625–13630, 2000.
View at: Publisher Site | Google Scholar
C. Morsczeck, W. Gotz, J. Schierholz et al., “Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth,” Matrix Biology, vol. 24, no. 2, pp. 155–165, 2005.
View at: Publisher Site | Google Scholar
W. Sonoyama, Y. Liu, D. Fang et al., “Mesenchymal stem cell-mediated functional tooth regeneration in swine,” PLoS One, vol. 1, no. 1, article e79, 2006.
View at: Publisher Site | Google Scholar
B.-M. Seo, M. Miura, S. Gronthos et al., “Investigation of multipotent postnatal stem cells from human periodontal ligament,” The Lancet, vol. 364, no. 9429, pp. 149–155, 2004.
View at: Publisher Site | Google Scholar
Q. Zhang, S. Shi, Y. Liu et al., “Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis,” Journal of Immunology, vol. 183, no. 12, pp. 7787–7798, 2009.
View at: Publisher Site | Google Scholar
S. A. Johnstone, M. Liley, M. J. Dalby, and S. C. Barnett, “Comparison of human olfactory and skeletal MSCs using osteogenic nanotopography to demonstrate bone-specific bioactivity of the surfaces,” Acta Biomaterialia, vol. 13, pp. 266–276, 2015.
View at: Publisher Site | Google Scholar
X. Shi, J. Mao, and Y. Liu, “Pulp stem cells derived from human permanent and deciduous teeth: biological characteristics and therapeutic applications,” Stem Cells Translational Medicine, vol. 9, no. 4, pp. 445–464, 2020.
View at: Publisher Site | Google Scholar
A. Bakopoulou, D. Apatzidou, E. Aggelidou et al., “Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects "stemness" properties,” Stem Cell Research & Therapy, vol. 8, no. 1, p. 247, 2017.
View at: Publisher Site | Google Scholar
G. Laino, R. d'Aquino, A. Graziano et al., “A new population of human adult dental pulp stem cells: a useful source of living autologous fibrous bone tissue (LAB),” Journal of Bone and Mineral Research, vol. 20, no. 8, pp. 1394–1402, 2005.
View at: Publisher Site | Google Scholar
K. H. Kwack, J. M. Lee, S. H. Park, and H. W. Lee, “Human dental pulp stem cells suppress alloantigen-induced immunity by stimulating T cells to release transforming growth factor Beta,” Journal of Endodontics, vol. 43, no. 1, pp. 100–108, 2017.
View at: Publisher Site | Google Scholar
N. Hossein-Khannazer, S. M. Hashemi, S. Namaki, H. Ghanbarian, and A. Khojasteh, “Study of the immunomodulatory effects of osteogenic differentiated human dental pulp stem cells,” Life Sciences, vol. 216, pp. 111–118, 2018.
View at: Publisher Site | Google Scholar
L. Li and J. Ge, “Exosome-derived lncRNA-Ankrd26 promotes dental pulp restoration by regulating miR-150-TLR4 signaling,” Molecular Medicine Reports, vol. 25, no. 5, 2022.
View at: Publisher Site | Google Scholar
W. Dong, J. Ge, P. Zhang et al., “Phenotypic characterization of craniofacial bone marrow stromal cells: unique properties of enhanced osteogenesis, cell recruitment, autophagy, and apoptosis resistance,” Cell and Tissue Research, vol. 358, no. 1, pp. 165–175, 2014.
View at: Publisher Site | Google Scholar
J. R. Millman, J. H. Tan, and C. K. Colton, “The effects of low oxygen on self-renewal and differentiation of embryonic stem cells,” Current Opinion in Organ Transplantation, vol. 14, no. 6, pp. 694–700, 2009.
View at: Publisher Site | Google Scholar
Y. Açil, F. Yang, A. Gulses, M. Ayna, J. Wiltfang, and M. Gierloff, “Isolation, characterization and investigation of differentiation potential of human periodontal ligament cells and dental follicle progenitor cells and their response to BMP-7 in vitro,” Odontology, vol. 104, no. 2, pp. 123–135, 2016.
View at: Publisher Site | Google Scholar
S. Tomic, J. Djokic, S. Vasilijic et al., “Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists,” Stem Cells and Development, vol. 20, no. 4, pp. 695–708, 2011.
View at: Publisher Site | Google Scholar
G. Ding, Y. Liu, Y. An et al., “Suppression of T cell proliferation by root apical papilla stem cells in vitro,” Cells, Tissues, Organs, vol. 191, no. 5, pp. 357–364, 2010.
View at: Publisher Site | Google Scholar
P. T. Dahake, N. P. Panpaliya, Y. J. Kale, M. V. Dadpe, S. B. Kendre, and C. Bogar, “Response of stem cells from human exfoliated deciduous teeth (SHED) to three bioinductive materials - an in vitro experimental study,” The Saudi Dental Journal, vol. 32, no. 1, pp. 43–51, 2020.
View at: Publisher Site | Google Scholar
T. Yamaza, A. Kentaro, C. Chen et al., “Immunomodulatory properties of stem cells from human exfoliated deciduous teeth,” Stem Cell Research & Therapy, vol. 1, no. 1, 2010.
View at: Publisher Site | Google Scholar
X. Gao, Z. Shen, M. Guan et al., “Immunomodulatory Role of Stem Cells from Human Exfoliated Deciduous Teeth on Periodontal Regeneration,” Tissue engineering, Part A, vol. 24, no. 17-18, pp. 1341–1353, 2018.
View at: Publisher Site | Google Scholar
C. Li, X. Wang, J. Tan, T. Wang, and Q. Wang, “The immunomodulatory properties of periodontal ligament stem cells isolated from inflamed periodontal granulation,” Cells, Tissues, Organs, vol. 199, no. 4, pp. 256–265, 2014.
View at: Google Scholar
C. Shin, M. Kim, J. A. Han et al., “Human periodontal ligament stem cells suppress T-cell proliferation via down- regulation of non-classical major histocompatibility complex-like glycoprotein CD1b on dendritic cells,” Journal of Periodontal Research, vol. 52, no. 1, pp. 135–146, 2017.
View at: Publisher Site | Google Scholar
S. H. Jin, J. E. Lee, J. H. Yun, I. Kim, Y. Ko, and J. B. Park, “Isolation and characterization of human mesenchymal stem cells from gingival connective tissue,” Journal of Periodontal Research, vol. 50, no. 4, pp. 461–467, 2015.
View at: Publisher Site | Google Scholar
A. Cicconetti, B. Sacchetti, A. Bartoli et al., “Human maxillary tuberosity and jaw periosteum as sources of osteoprogenitor cells for tissue engineering,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 104, no. 5, pp. 618.e1–618.e12, 2007.
View at: Publisher Site | Google Scholar
Y. Pu, M. Wang, Y. Hong, Y. Wu, and Z. Tang, “Adiponectin promotes human jaw bone marrow mesenchymal stem cell chemotaxis via CXCL1 and CXCL8,” Journal of Cellular and Molecular Medicine, vol. 21, no. 7, pp. 1411–1419, 2017.
View at: Publisher Site | Google Scholar
H. Hu, Y. Pu, S. Lu et al., “The osteogenesis effect and underlying mechanisms of local delivery of gAPN in extraction sockets of beagle dogs,” International Journal of Molecular Sciences, vol. 16, no. 10, pp. 24946–24964, 2015.
View at: Publisher Site | Google Scholar
Y. Pu, H. Wu, S. Lu et al., “Adiponectin promotes human jaw bone marrow stem cell osteogenesis,” Journal of Dental Research, vol. 95, no. 7, pp. 769–775, 2016.
View at: Publisher Site | Google Scholar
S. O. Akintoye, T. Lam, S. Shi, J. Brahim, M. T. Collins, and P. G. Robey, “Skeletal site-specific characterization of orofacial and iliac crest human bone marrow stromal cells in same individuals,” Bone, vol. 38, no. 6, pp. 758–768, 2006.
View at: Publisher Site | Google Scholar
H. Pan, N. Cai, M. Li, G. H. Liu, and J. C. Izpisua Belmonte, “Autophagic control of cell 'stemness',” EMBO Molecular Medicine, vol. 5, no. 3, pp. 327–331, 2013.
View at: Publisher Site | Google Scholar
Y. Chai, X. Jiang, Y. Ito et al., “Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis,” Development, vol. 127, no. 8, pp. 1671–1679, 2000.
View at: Publisher Site | Google Scholar
E. J. Mackie, Y. A. Ahmed, L. Tatarczuch, K. S. Chen, and M. Mirams, “Endochondral ossification: how cartilage is converted into bone in the developing skeleton,” The International Journal of Biochemistry & Cell Biology, vol. 40, no. 1, pp. 46–62, 2008.
View at: Publisher Site | Google Scholar
A. Mavropoulos, R. Rizzoli, and P. Ammann, “Different responsiveness of alveolar and tibial bone to bone loss stimuli,” Journal of Bone and Mineral Research, vol. 22, no. 3, pp. 403–410, 2007.
View at: Publisher Site | Google Scholar
T. L. Aghaloo, T. Chaichanasakul, O. Bezouglaia et al., “Osteogenic potential of mandibular vs. long-bone marrow stromal cells,” Journal of Dental Research, vol. 89, no. 11, pp. 1293–1298, 2010.
View at: Publisher Site | Google Scholar
R. Aanismaa, J. Hautala, A. Vuorinen, S. Miettinen, and S. Narkilahti, “Human dental pulp stem cells differentiate into neural precursors but not into mature functional neurons,” Stem Cell Discovery, vol. 2, no. 3, pp. 85–91, 2012.
View at: Publisher Site | Google Scholar
E. Karaöz, P. C. Demircan, O. Sağlam, A. Aksoy, F. Kaymaz, and G. Duruksu, “Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells,” Histochemistry and Cell Biology, vol. 136, no. 4, pp. 455–473, 2011.
View at: Publisher Site | Google Scholar
M. Kiraly, B. Porcsalmy, A. Pataki et al., “Simultaneous PKC and cAMP activation induces differentiation of human dental pulp stem cells into functionally active neurons,” Neurochemistry International, vol. 55, no. 5, pp. 323–332, 2009.
View at: Publisher Site | Google Scholar
I. V. Nosrat, C. A. Smith, P. Mullally, L. Olson, and C. A. Nosrat, “Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system,” The European Journal of Neuroscience, vol. 19, no. 9, pp. 2388–2398, 2004.
View at: Publisher Site | Google Scholar
M. Song, S. S. Jue, Y. A. Cho, and E. C. Kim, “Comparison of the effects of human dental pulp stem cells and human bone marrow-derived mesenchymal stem cells on ischemic human astrocytes in vitro,” Journal of Neuroscience Research, vol. 93, no. 6, pp. 973–983, 2015.
View at: Publisher Site | Google Scholar
M. Saharkhiz, M. Ayadilord, F. Emadian Razavi, and M. Naseri, “Effects of phytosomal curcumin treatment on modulation of immunomodulatory and pulp regeneration genes in dental pulp mesenchymal stem cells,” Odontology, vol. 110, no. 2, pp. 287–295, 2022.
View at: Publisher Site | Google Scholar
H. Wang, M. Sun, J. Sun, P. Gong, N. Liu, and M. Wang, “Dental pulp stem cell therapy in ischemic stroke: a meta-analysis of preclinical studies,” Journal of Stroke and Cerebrovascular Diseases, vol. 31, no. 6, article 106453, 2022.
View at: Publisher Site | Google Scholar
A. H. Huang, Y. K. Chen, L. M. Lin, T. Y. Shieh, and A. W. Chan, “Isolation and characterization of dental pulp stem cells from a supernumerary tooth,” Journal of Oral Pathology & Medicine, vol. 37, no. 9, pp. 571–574, 2008.
View at: Publisher Site | Google Scholar
Y. Fujii, Y. Kawase-Koga, H. Hojo et al., “Bone regeneration by human dental pulp stem cells using a helioxanthin derivative and cell-sheet technology,” Stem Cell Research & Therapy, vol. 9, no. 1, p. 24, 2018.
View at: Publisher Site | Google Scholar
J. Tian, W. Chen, Y. Xiong et al., “Small extracellular vesicles derived from hypoxic preconditioned dental pulp stem cells ameliorate inflammatory osteolysis by modulating macrophage polarization and osteoclastogenesis,” Bioactive Materials, vol. 22, pp. 326–342, 2023.
View at: Publisher Site | Google Scholar
I. Angelopoulos, C. Brizuela, and M. Khoury, “Gingival mesenchymal stem cells outperform haploidentical dental pulp-derived mesenchymal stem cells in proliferation rate, migration ability, and angiogenic potential,” Cell Transplantation, vol. 27, no. 6, pp. 967–978, 2018.
View at: Publisher Site | Google Scholar
M. D. Mercado-Rubio, E. Pérez-Argueta, A. Zepeda-Pedreguera et al., “Similar features, different behaviors: a comparative in vitro study of the adipogenic potential of stem cells from human follicle, dental pulp, and periodontal ligament,” Journal of Personalized Medicine, vol. 11, no. 8, p. 738, 2021.
View at: Publisher Site | Google Scholar
L. Lin, Y. Zheng, C. Wang, P. Li, D. Xu, and W. Zhao, “Concentration-dependent cellular uptake of graphene oxide quantum dots promotes the odontoblastic differentiation of dental pulp cells via the AMPK/mTOR pathway,” ACS Omega, vol. 8, no. 6, pp. 5393–5405, 2023.
View at: Publisher Site | Google Scholar
B. Sramkó, A. Földes, K. Kádár, G. Varga, Á. Zsembery, and K. Pircs, “The wisdom in teeth: neuronal differentiation of dental pulp cells,” Cellular Reprogramming, vol. 25, no. 1, pp. 32–44, 2023.
View at: Publisher Site | Google Scholar
C. Yang, L. Sun, X. Li et al., “The potential of dental stem cells differentiating into neurogenic cell lineage after cultivation in different modes in vitro,” Cellular Reprogramming, vol. 16, no. 5, pp. 379–391, 2014.
View at: Publisher Site | Google Scholar
K. Lott, P. Collier, M. Ringor, K. M. Howard, and K. Kingsley, “Administration of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) to induce neural differentiation of dental pulp stem cells (DPSC) isolates,” Biomedicine, vol. 11, no. 2, 2023.
View at: Publisher Site | Google Scholar
Y. Bai, X. Cheng, X. Liu et al., “Transforming growth factor-β1 promotes early odontoblastic differentiation of dental pulp stem cells via activating AKT, Erk1/2 and p38 MAPK pathways,” Journal of Dental Sciences, vol. 18, no. 1, pp. 87–94, 2023.
View at: Publisher Site | Google Scholar
M. Matsui, T. Kobayashi, and T. W. Tsutsui, “CD146 positive human dental pulp stem cells promote regeneration of dentin/pulp-like structures,” Human Cell, vol. 31, no. 2, pp. 127–138, 2018.
View at: Publisher Site | Google Scholar
D. Genç, M. Sezer Kürkçü, G. Yiğittürk et al., “Synovial fluid niche promoted differentiation of dental follicle mesenchymal stem cells toward chondrogenesis in rheumatoid arthritis,” Archives of Rheumatology, vol. 37, no. 1, pp. 94–109, 2022.
View at: Publisher Site | Google Scholar
K. Shoi, K. Aoki, K. Ohya, Y. Takagi, and H. Shimokawa, “Characterization of pulp and follicle stem cells from impacted supernumerary maxillary incisors,” Pediatric Dentistry, vol. 36, no. 3, pp. 79–84, 2014.
View at: Google Scholar
M. Rezai Rad, D. Liu, H. He et al., “The role of dentin matrix protein 1 (DMP1) in regulation of osteogenic differentiation of rat dental follicle stem cells (DFSCs),” Archives of Oral Biology, vol. 60, no. 4, pp. 546–556, 2015.
View at: Publisher Site | Google Scholar
H. Liang, Q. Li, N. Wang et al., “KDM4D enhances osteo/dentinogenic differentiation and migration of SCAPs via binding to RPS5,” Oral Diseases, 2022.
View at: Publisher Site | Google Scholar
X. Zhuang, L. Ji, H. Jiang et al., “Exosomes derived from stem cells from the apical papilla promote dentine-pulp complex regeneration by inducing specific dentinogenesis,” Stem Cells International, vol. 2020, Article ID 5816723, 10 pages, 2020.
View at: Publisher Site | Google Scholar
M. Miura, S. Gronthos, M. Zhao et al., “SHED: stem cells from human exfoliated deciduous teeth,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 10, pp. 5807–5812, 2003.
View at: Publisher Site | Google Scholar
J. Wu, L. Chen, R. Wang et al., “Exosomes secreted by stem cells from human exfoliated deciduous teeth promote alveolar bone defect repair through the regulation of angiogenesis and osteogenesis,” ACS Biomaterials Science & Engineering, vol. 5, no. 7, pp. 3561–3571, 2019.
View at: Publisher Site | Google Scholar
A. Wang, J. Liu, X. Zhuang et al., “Identification and comparison of piRNA expression profiles of exosomes derived from human stem cells from the apical papilla and bone marrow mesenchymal stem cells,” Stem Cells and Development, vol. 29, no. 8, pp. 511–520, 2020.
View at: Publisher Site | Google Scholar
X. Y. Xu, B. M. Tian, Y. Xia et al., “Exosomes derived from P2X7 receptor gene-modified cells rescue inflammation-compromised periodontal ligament stem cells from dysfunction,” Stem Cells Translational Medicine, vol. 9, no. 11, pp. 1414–1430, 2020.
View at: Publisher Site | Google Scholar
T. Liu, W. Hu, X. Zou et al., “Human periodontal ligament stem cell-derived exosomes promote bone regeneration by altering MicroRNA profiles,” Stem Cells International, vol. 2020, Article ID 8852307, 13 pages, 2020.
View at: Publisher Site | Google Scholar
Z. Zhang, Y. Shuai, F. Zhou et al., “PDLSCs regulate angiogenesis of periodontal ligaments via VEGF transferred by exosomes in periodontitis,” International Journal of Medical Sciences, vol. 17, no. 5, pp. 558–567, 2020.
View at: Publisher Site | Google Scholar
I. C. Gay, S. Chen, and M. MacDougall, “Isolation and characterization of multipotent human periodontal ligament stem cells,” Orthodontics & Craniofacial Research, vol. 10, no. 3, pp. 149–160, 2007.
View at: Publisher Site | Google Scholar
W. Wu, Z. Xiao, Y. Chen et al., “CD39 produced from human GMSCs regulates the balance of osteoclasts and osteoblasts through the Wnt/β-catenin pathway in osteoporosis,” Molecular Therapy, vol. 28, no. 6, pp. 1518–1532, 2020.
View at: Publisher Site | Google Scholar
M. M. Hasani-Sadrabadi, P. Sarrion, S. Pouraghaei et al., “An engineered cell-laden adhesive hydrogel promotes craniofacial bone tissue regeneration in rats,” Science Translational Medicine, vol. 12, no. 534, 2020.
View at: Publisher Site | Google Scholar
S. Jin, C. Yang, J. Huang et al., “Conditioned medium derived from FGF-2-modified GMSCs enhances migration and angiogenesis of human umbilical vein endothelial cells,” Stem Cell Research & Therapy, vol. 11, no. 1, p. 68, 2020.
View at: Publisher Site | Google Scholar
Q. Zhang, J. C. Burrell, J. Zeng et al., “Implantation of a nerve protector embedded with human GMSC-derived Schwann-like cells accelerates regeneration of crush-injured rat sciatic nerves,” Stem Cell Research & Therapy, vol. 13, no. 1, p. 263, 2022.
View at: Publisher Site | Google Scholar
S. D. Girard, A. Devéze, E. Nivet, B. Gepner, F. S. Roman, and F. Féron, “Isolating nasal olfactory stem cells from rodents or humans,” Journal of Visualized Experiments, vol. 54, no. 54, 2011.
View at: Publisher Site | Google Scholar
B. Delorme, E. Nivet, J. Gaillard et al., “The human nose harbors a niche of olfactory ectomesenchymal stem cells displaying neurogenic and osteogenic properties,” Stem Cells and Development, vol. 19, no. 6, pp. 853–866, 2010.
View at: Publisher Site | Google Scholar
W. Murrell, F. Féron, A. Wetzig et al., “Multipotent stem cells from adult olfactory mucosa,” Developmental Dynamics, vol. 233, no. 2, pp. 496–515, 2005.
View at: Publisher Site | Google Scholar
C. Son, M. S. Choi, and J. C. Park, “Different responsiveness of alveolar bone and long bone to epithelial-mesenchymal interaction-related factor,” JBMR Plus, vol. 4, no. 8, article e10382, 2020.
View at: Publisher Site | Google Scholar
J. S. Park, G. Park, and H. S. Hong, “Age affects the paracrine activity and differentiation potential of human adipose-derived stem cells,” Molecular Medicine Reports, vol. 23, no. 2, 2021.
View at: Publisher Site | Google Scholar
D. R. Morse, “Age-related changes of the dental pulp complex and their relationship to systemic aging,” Oral Surgery, Oral Medicine, and Oral Pathology, vol. 72, no. 6, pp. 721–745, 1991.
View at: Publisher Site | Google Scholar
T. A. Mitsiadis, C. De Bari, and I. About, “Apoptosis in developmental and repair-related human tooth remodeling: a view from the inside,” Experimental Cell Research, vol. 314, no. 4, pp. 869–877, 2008.
View at: Publisher Site | Google Scholar
M. Sato, Y. Kawase-Koga, D. Yamakawa, Y. Fujii, and D. Chikazu, “Bone regeneration potential of human dental pulp stem cells derived from elderly patients and osteo-induced by a helioxanthin derivative,” International Journal of Molecular Sciences, vol. 21, no. 20, p. 7731, 2020.
View at: Publisher Site | Google Scholar
J. D. Kretlow, Y. Q. Jin, W. Liu et al., “Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells,” BMC Cell Biology, vol. 9, no. 1, p. 60, 2008.
View at: Publisher Site | Google Scholar
W. Wu, J. Zhou, C. T. Xu, J. Zhang, Y. J. Jin, and G. L. Sun, “Derivation and growth characteristics of dental pulp stem cells from patients of different ages,” Molecular Medicine Reports, vol. 12, no. 4, pp. 5127–5134, 2015.
View at: Publisher Site | Google Scholar
Y. Wang, X. Chen, W. Cao, and Y. Shi, “Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications,” Nature Immunology, vol. 15, no. 11, pp. 1009–1016, 2014.
View at: Publisher Site | Google Scholar
T. J. Kean, P. Lin, A. I. Caplan, and J. E. Dennis, “MSCs: delivery routes and engraftment, cell-targeting strategies, and immune modulation,” Stem Cells International, vol. 2013, Article ID 732742, 13 pages, 2013.
View at: Publisher Site | Google Scholar
M. Matsumura-Kawashima, K. Ogata, M. Moriyama, Y. Murakami, T. Kawado, and S. Nakamura, “Secreted factors from dental pulp stem cells improve Sjögren's syndrome via regulatory T cell-mediated immunosuppression,” Stem Cell Research & Therapy, vol. 12, no. 1, p. 182, 2021.
View at: Publisher Site | Google Scholar
A. Doaa and V. Han, “Different effects of insulin-like growth factor-1 and insulin-like growth factor-2 on myogenic differentiation of human mesenchymal stem cells,” Stem Cells International, vol. 2017, Article ID 8286248, 15 pages, 2017.
View at: Publisher Site | Google Scholar
A. Gebler, O. Zabel, and B. Seliger, “The immunomodulatory capacity of mesenchymal stem cells,” Trends in Molecular Medicine, vol. 18, no. 2, pp. 128–134, 2012.
View at: Publisher Site | Google Scholar
S. Tipnis, C. Viswanathan, and A. S. Majumdar, “Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO,” Immunology and Cell Biology, vol. 88, no. 8, pp. 795–806, 2010.
View at: Publisher Site | Google Scholar
S. J. Cui, T. Zhang, Y. Fu et al., “DPSCs attenuate experimental progressive TMJ arthritis by inhibiting the STAT1 pathway,” Journal of Dental Research, vol. 99, no. 4, pp. 446–455, 2020.
View at: Publisher Site | Google Scholar
G. Ren, L. Zhang, Z. Xin et al., “Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide,” Cell Stem Cell, vol. 2, no. 2, pp. 141–150, 2008.
View at: Publisher Site | Google Scholar
R. Anzalone, M. L. Iacono, S. Corrao et al., “New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity,” Stem Cells and Development, vol. 19, no. 4, pp. 423–438, 2010.
View at: Publisher Site | Google Scholar
N. Wada, D. Menicanin, S. Shi, P. M. Bartold, and S. Gronthos, “Immunomodulatory properties of human periodontal ligament stem cells,” Journal of Cellular Physiology, vol. 219, no. 3, pp. 667–676, 2009.
View at: Publisher Site | Google Scholar
T. Struys, M. Moreels, W. Martens, R. Donders, E. Wolfs, and I. Lambrichts, “Ultrastructural and immunocytochemical analysis of multilineage differentiated human dental pulp- and umbilical cord-derived mesenchymal stem cells,” Cells, Tissues, Organs, vol. 193, no. 6, pp. 366–378, 2011.
View at: Publisher Site | Google Scholar
Y. Xia, H. N. Tang, R. X. Wu, Y. Yu, L. N. Gao, and F. M. Chen, “Cell responses to conditioned media produced by patient-matched stem cells derived from healthy and inflamed periodontal ligament tissues,” Journal of Periodontology, vol. 87, no. 5, pp. e53–e63, 2015.
View at: Publisher Site | Google Scholar
Ê. J. Bassi, C. A. M. Aita, and N. O. S. Câmara, “Immune regulatory properties of multipotent mesenchymal stromal cells: where do we stand?” World Journal of Stem Cells, vol. 3, no. 1, pp. 1–8, 2011.
View at: Publisher Site | Google Scholar
A. Tuettenberg, C. Becker, A. Correll, K. Steinbrink, and H. Jonuleit, “Immune regulation by dendritic cells and T cells-basic science, diagnostic, and clinical application,” Clinical Laboratory, vol. 57, no. 1-2, pp. 1–12, 2011.
View at: Google Scholar
F. D. S. Silva, R. N. Ramos, D. C. D. Almeida et al., “Mesenchymal stem cells derived from human exfoliated deciduous teeth (SHEDs) induce immune modulatory profile in monocyte-derived dendritic cells,” PLoS One, vol. 9, no. 5, article e98050, 2014.
View at: Google Scholar
W. R. Su, Q. Z. Zhang, S. H. Shi, A. L. Nguyen, and A. D. Le, “Human gingiva-derived mesenchymal stromal cells attenuate contact hypersensitivity via prostaglandin E₂-dependent mechanisms,” Stem Cells, vol. 29, no. 11, pp. 1849–1860, 2011.
View at: Publisher Site | Google Scholar
T. A. Wynn and K. M. Vannella, “Macrophages in tissue repair, regeneration, and fibrosis,” Immunity, vol. 44, no. 3, pp. 450–462, 2016.
View at: Publisher Site | Google Scholar
C. K. Glass and G. Natoli, “Molecular control of activation and priming in macrophages,” Nature Immunology, vol. 17, no. 1, pp. 26–33, 2015.
View at: Publisher Site | Google Scholar
D. M. Mosser and J. P. Edwards, “Exploring the full spectrum of macrophage activation,” Nature Reviews Immunology, vol. 8, no. 12, pp. 958–969, 2008.
View at: Publisher Site | Google Scholar
Q. Z. Zhang, W. R. Su, S. H. Shi et al., “Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing,” Stem Cells, vol. 28, no. 10, pp. 1856–1868, 2010.
View at: Publisher Site | Google Scholar
M. Omi, M. Hata, N. Nakamura et al., “Transplantation of dental pulp stem cells suppressed inflammation in sciatic nerves by promoting macrophage polarization towards anti-inflammation phenotypes and ameliorated diabetic polyneuropathy,” Journal of Diabetes Investigation, vol. 7, no. 4, pp. 485–496, 2016.
View at: Publisher Site | Google Scholar
L. Zhao, I. Kang, X. Fang et al., “Gamma-tocotrienol attenuates high-fat diet-induced obesity and insulin resistance by inhibiting adipose inflammation and M1 macrophage recruitment,” International Journal of Obesity, vol. 39, no. 3, pp. 438–446, 2015.
View at: Publisher Site | Google Scholar
S. M. Kaech and W. Cui, “Transcriptional control of effector and memory CD8+ T cell differentiation,” Nature Reviews Immunology, vol. 261, no. 1, pp. 157–168, 2015.
View at: Google Scholar
P. Soroosh and T. A. Doherty, “Th9 and allergic disease,” Immunology, vol. 127, no. 4, pp. 450–458, 2009.
View at: Publisher Site | Google Scholar
A. O'Garra, “Cytokines induce the development of functionally heterogeneous T helper cell subsets,” Immunity, vol. 8, no. 3, pp. 275–283, 1998.
View at: Publisher Site | Google Scholar
G. Ren, Z. Xin, L. Zhang et al., “Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression,” Journal of Immunology, vol. 184, no. 5, pp. 2321–2328, 2010.
View at: Publisher Site | Google Scholar
A. T. Özdemir, R. B. Özgül Özdemir, C. Kırmaz et al., “The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets,” Cellular Immunology, vol. 310, pp. 108–115, 2016.
View at: Publisher Site | Google Scholar
D. Liu, J. Xu, O. Liu et al., “Mesenchymal stem cells derived from inflamed periodontal ligaments exhibit impaired immunomodulation,” Journal of Clinical Periodontology, vol. 39, no. 12, pp. 1174–1182, 2012.
View at: Publisher Site | Google Scholar
P. C. Demircan, A. E. Sariboyaci, Z. S. Unal, G. Gacar, C. Subasi, and E. Karaoz, “Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems,” Cytotherapy, vol. 13, no. 10, pp. 1205–1220, 2011.
View at: Publisher Site | Google Scholar
Y. Zhao, L. Wang, Y. Jin, and S. Shi, “Fas ligand regulates the immunomodulatory properties of dental pulp stem cells,” Journal of Dental Research, vol. 91, no. 10, pp. 948–954, 2012.
View at: Publisher Site | Google Scholar
D. Depoil, M. Weber, B. Treanor et al., “Early events of B cell activation by AntigenA presentation from the 12th Joint Meeting of the Signal Transduction Society, Weimar, Germany, 29 to 31 October 2008,” Science Signaling, vol. 2, no. 63, 2009.
View at: Publisher Site | Google Scholar
N. S. Silva and U. Klein, “Dynamics of B cells in germinal centres,” Nature Reviews Immunology, vol. 15, no. 3, pp. 137–148, 2015.
View at: Publisher Site | Google Scholar
M. E. Bernardo, F. Locatelli, and W. E. Fibbe, “Mesenchymal stromal cells,” Annals of the New York Academy of Sciences, vol. 1176, no. 1, pp. 101–117, 2009.
View at: Publisher Site | Google Scholar
M. Krampera, L. Cosmi, R. Angeli et al., “Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells,” Stem Cells, vol. 24, no. 2, pp. 386–398, 2006.
View at: Publisher Site | Google Scholar
M. Krampera, “Mesenchymal stromal cell 'licensing': a multistep process,” Leukemia, vol. 25, no. 9, pp. 1408–1414, 2011.
View at: Publisher Site | Google Scholar
O. Andrukhov, J. S. A. Hong, O. Andrukhova, A. Blufstein, A. Moritz, and X. Rausch-Fan, “Response of human periodontal ligament stem cells to IFN-γ and TLR-agonists,” Scientific Reports, vol. 7, no. 1, p. 12856, 2017.
View at: Publisher Site | Google Scholar
K. Kadar, M. Kiraly, B. Porcsalmy et al., “Differentiation potential of stem cells from human dental origin - promise for tissue engineering,” Journal of Physiology and Pharmacology, vol. 60, Supplement 7, pp. 167–175, 2009.
View at: Google Scholar
E. Uzunoglu-Ozyurek, G. Önal, and S. Dökmeci, “Odonto/osteogenic differentiation of dental pulp stem cells of type 1 diabetic patients with mineral trioxide aggregate/1α,25-dihydroxyvitamin D3 combination,” Journal of Endodontia, vol. 48, no. 4, pp. 516–526, 2022.
View at: Publisher Site | Google Scholar
T. Staniowski, A. Zawadzka-Knefel, and K. Skośkiewicz-Malinowska, “Therapeutic potential of dental pulp stem cells according to different transplant types,” Molecules, vol. 26, no. 24, p. 7423, 2021.
View at: Publisher Site | Google Scholar
E. Ledesma-Martínez, V. M. Mendoza-Núñez, and E. Santiago-Osorio, “Mesenchymal stem cells derived from dental pulp: a review,” Stem Cells International, vol. 2016, Article ID 4709572, 12 pages, 2016.
View at: Publisher Site | Google Scholar
Y. Itoh, J. I. Sasaki, M. Hashimoto, C. Katata, M. Hayashi, and S. Imazato, “Pulp regeneration by 3-dimensional dental pulp stem cell constructs,” Journal of Dental Research, vol. 97, no. 10, pp. 1137–1143, 2018.
View at: Publisher Site | Google Scholar
J. Ishikawa, N. Takahashi, T. Matsumoto et al., “Factors secreted from dental pulp stem cells show multifaceted benefits for treating experimental rheumatoid arthritis,” Bone, vol. 83, pp. 210–219, 2016.
View at: Publisher Site | Google Scholar
I. Berniakovich and M. Giorgio, “Low oxygen tension maintains multipotency, whereas normoxia increases differentiation of mouse bone marrow stromal cells,” International Journal of Molecular Sciences, vol. 14, no. 1, pp. 2119–2134, 2013.
View at: Publisher Site | Google Scholar
S. Tsutsumi, A. Shimazu, K. Miyazaki et al., “Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF,” Biochemical and Biophysical Research Communications, vol. 288, no. 2, pp. 413–419, 2001.
View at: Publisher Site | Google Scholar
A. Stolzing, E. Jones, D. McGonagle, and A. Scutt, “Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies,” Mechanisms of Ageing and Development, vol. 129, no. 3, pp. 163–173, 2008.
View at: Publisher Site | Google Scholar
J. Su, X. Chen, Y. Huang et al., “Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell- mediated immunosuppression in mammalian species,” Cell Death & Differentiation, vol. 21, no. 3, pp. 388–396, 2014.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2023 Zhenning Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

424

Downloads

381

Citations